Hepatology Forum

Scope & Guideline

Fostering collaboration in the fight against liver disorders.

Introduction

Explore the comprehensive scope of Hepatology Forum through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Hepatology Forum in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1307-5888
PublisherKARE PUBL
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationHEPATOL FORUM / Hepatol. Forum
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGoztepe Mah. Fahrettin Kerim Gokay Caddesi. No: 200/A D:2 Cemenzar - Kadkoy, ISTANBUL 34720, Turkiye

Aims and Scopes

The journal 'Hepatology Forum' focuses on advancing the understanding and treatment of liver diseases through innovative research and clinical practice. Its aims and scopes encompass a wide range of topics related to hepatology, aiming to bridge the gap between laboratory findings and clinical applications.
  1. Liver Disease Mechanisms and Pathophysiology:
    Research exploring the underlying mechanisms of various liver diseases, including hepatitis, fatty liver diseases, and liver cancer, contributes to a deeper understanding of disease progression and management.
  2. Transplantation and Surgical Interventions:
    The journal emphasizes studies on liver transplantation, including donor selection, surgical techniques, and post-operative care, which are crucial for improving patient outcomes.
  3. Innovative Diagnostic Approaches:
    The publication covers advancements in diagnostic methodologies, such as imaging techniques and biomarker identification, enhancing the accuracy and efficiency of liver disease diagnoses.
  4. Therapeutic Strategies and Clinical Trials:
    A significant focus is placed on novel therapeutic interventions for liver diseases, including pharmacological treatments, dietary modifications, and alternative therapies, supported by clinical trial data.
  5. Public Health and Epidemiology:
    The journal addresses the epidemiological aspects of liver diseases, including prevalence studies and risk factor assessments, to inform public health strategies and resource allocation.
  6. Genetic and Molecular Research:
    Research investigating genetic predispositions and molecular pathways involved in liver diseases is a core area, contributing to personalized medicine approaches in hepatology.
The journal has observed several emerging themes that reflect the evolving landscape of hepatology research. These trends indicate a growing interest in innovative methodologies and pressing clinical issues.
  1. Metabolic Dysfunction-Associated Liver Disease (MASLD):
    Recent publications indicate a significant increase in research focused on metabolic dysfunction-associated liver disease, reflecting its rising prevalence and importance in the context of global health.
  2. Artificial Intelligence in Hepatology:
    The integration of artificial intelligence for predictive modeling and diagnostic purposes in liver disease management is gaining traction, highlighting a trend towards utilizing technology in clinical practice.
  3. Impact of COVID-19 on Liver Health:
    The exploration of COVID-19's effects on liver diseases, including complications and management strategies, has emerged as a critical area of research in light of the pandemic's ongoing impact.
  4. Personalized Medicine and Genetic Studies:
    There is a growing trend towards personalized medicine, with an emphasis on genetic studies that tailor treatment approaches based on individual patient profiles and genetic backgrounds.
  5. Non-Invasive Assessment Techniques:
    The rise of non-invasive techniques for assessing liver conditions, such as elastography and biochemical markers, reflects an emerging focus on improving patient comfort and clinical outcomes.

Declining or Waning

While 'Hepatology Forum' continues to cover a broad spectrum of topics, certain areas have shown a decline in publication frequency and relevance over recent years. This may reflect shifting clinical priorities or advancements in other research domains.
  1. Traditional Pharmaceutical Treatments:
    There appears to be a waning focus on older, conventional pharmacological treatments for liver diseases, possibly due to the emergence of more effective and targeted therapies.
  2. Basic Science Without Clinical Application:
    Research that primarily explores basic science without clear clinical implications or applications is becoming less prominent, as the journal increasingly emphasizes translational research.
  3. Case Reports of Rare Conditions:
    While case reports provide valuable insights, the frequency of publications on rare liver conditions has diminished, likely as the journal prioritizes studies with broader clinical relevance.

Similar Journals

Clinics in Liver Disease

Unveiling the complexities of hepatology for better care.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1089-3261Frequency: 4 issues/year

Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.

Gastroenterologia y Hepatologia

Pioneering research for better digestive disease outcomes.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Innovating Insights into Gastroenterology and Hepatology
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1857Frequency: 12 issues/year

American Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.

Korean Journal of Gastroenterology

Connecting Disciplines for Gastroenterological Excellence
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Canadian Journal of Gastroenterology and Hepatology

Advancing Knowledge in Gastroenterology and Hepatology
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

International Journal of Hepatology

Connecting researchers and clinicians for better liver health.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

LIVER INTERNATIONAL

Innovating liver research for a healthier tomorrow.
Publisher: WILEYISSN: 1478-3223Frequency: 12 issues/year

LIVER INTERNATIONAL, with its ISSN 1478-3223 and E-ISSN 1478-3231, is a prestigious peer-reviewed journal published by Wiley in the United Kingdom. Established in 2003, it focuses on advancing the field of hepatology, covering a broad spectrum of topics including liver disease, hepatocellular carcinoma, and transplantation. Ranking #10 out of 82 in the Scopus category for Medicine - Hepatology and boasting a remarkable 88th percentile, LIVER INTERNATIONAL has secured its reputation as a leading journal, recognized as Q1 in the 2023 category quartiles. The journal emphasizes accessibility, offering an open access option to ensure that critical research findings reach a wider audience. By facilitating the dissemination of high-quality research, LIVER INTERNATIONAL plays a vital role in shaping contemporary hepatological discourse and bridging academic inquiry with clinical practice, making it an essential resource for researchers, healthcare professionals, and students alike.

Gastrointestinal Disorders

Unlocking Knowledge in Gastrointestinal Disorders for All
Publisher: MDPIISSN: Frequency: 4 issues/year

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

Hepatology International

Elevating global hepatology research to new heights.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.

Annals of Hepatology

Advancing liver research, one article at a time.
Publisher: ELSEVIER ESPANAISSN: 1665-2681Frequency: 6 issues/year

Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.